These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2573869)

  • 1. Lewy bodies in tyrosine hydroxylase-synthesizing neurons of the human cerebral cortex.
    Kuljis RO; Martín-Vasallo P; Peress NS
    Neurosci Lett; 1989 Nov; 106(1-2):49-54. PubMed ID: 2573869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinson's disease and dementia with neuronal inclusions in the cerebral cortex: Lewy bodies or Pick bodies.
    Tiller-Borcich JK; Forno LS
    J Neuropathol Exp Neurol; 1988 Sep; 47(5):526-35. PubMed ID: 2845001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The presence of tau distinguishes Lewy bodies of diffuse Lewy body disease from those of idiopathic Parkinson disease.
    Galloway PG; Bergeron C; Perry G
    Neurosci Lett; 1989 May; 100(1-3):6-10. PubMed ID: 2548130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneous inclusions in neurofilament inclusion disease.
    Uchikado H; Li A; Lin WL; Dickson DW
    Neuropathology; 2006 Oct; 26(5):417-21. PubMed ID: 17080718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degeneration of tyrosine hydroxylase-immunoreactive neurons in the cerebral cortex and hippocampus of patients with dementia with Lewy bodies.
    Marui W; Iseki E; Kato M; Kosaka K
    Neurosci Lett; 2003 Apr; 340(3):185-8. PubMed ID: 12672537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphology of tyrosine hydroxylase-immunoreactive neurons in the human cerebral cortex.
    Hornung JP; Törk I; De Tribolet N
    Exp Brain Res; 1989; 76(1):12-20. PubMed ID: 2568941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classic and generalized variants of Pick's disease: a clinicopathological, ultrastructural, and immunocytochemical comparative study.
    Munoz-Garcia D; Ludwin SK
    Ann Neurol; 1984 Oct; 16(4):467-80. PubMed ID: 6093681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NIFID: a new molecular pathology with a frontotemporal dementia phenotype.
    DeKosky ST; Ikonomovic MD
    Neurology; 2004 Oct; 63(8):1348-9. PubMed ID: 15505145
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunohistochemistry of neuronal inclusions in the cerebral cortex and brain-stem in Lewy body disease.
    Fukuda T; Tanaka J; Watabe K; Numoto RT; Minamitani M
    Acta Pathol Jpn; 1993 Oct; 43(10):545-51. PubMed ID: 8291442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lewy body dementia without Alzheimer changes.
    Sima AA; Clark AW; Sternberger NA; Sternberger LA
    Can J Neurol Sci; 1986 Nov; 13(4 Suppl):490-7. PubMed ID: 3024794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential distribution of a neurofilament protein epitope in acetylcholinesterase-rich neurons of human cerebral neocortex.
    Mesulam M; Geula C
    Brain Res; 1991 Mar; 544(1):169-73. PubMed ID: 1713114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine hydroxylase-immunoreactive neurons in the mouse cerebral cortex during the postnatal period.
    Satoh J; Suzuki K
    Brain Res Dev Brain Res; 1990 Apr; 53(1):1-5. PubMed ID: 1972039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal inclusions of Parkinson's disease.
    Gibb WR; Scott T; Lees AJ
    Mov Disord; 1991; 6(1):2-11. PubMed ID: 1848677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient expression of tyrosine hydroxylase immunoreactivity in some neurons of the rat neocortex during postnatal development.
    Berger B; Verney C; Gaspar P; Febvret A
    Brain Res; 1985 Nov; 355(1):141-4. PubMed ID: 2866813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine hydroxylase is expressed by neocortical neurons after transplantation.
    Park JK; Joh TH; Ebner FF
    Proc Natl Acad Sci U S A; 1986 Oct; 83(19):7495-8. PubMed ID: 2876427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse Lewy body disease.
    Lennox G; Lowe J; Byrne EJ; Landon M; Mayer RJ; Godwin-Austen RB
    Lancet; 1989 Feb; 1(8633):323-4. PubMed ID: 2563473
    [No Abstract]   [Full Text] [Related]  

  • 17. Epitope map of neurofilament protein domains in cortical and peripheral nervous system Lewy bodies.
    Schmidt ML; Murray J; Lee VM; Hill WD; Wertkin A; Trojanowski JQ
    Am J Pathol; 1991 Jul; 139(1):53-65. PubMed ID: 1713021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for neurofilament inclusion disease using alpha-internexin immunohistochemistry.
    Uchikado H; Shaw G; Wang DS; Dickson DW
    Neurology; 2005 May; 64(9):1658-9. PubMed ID: 15883343
    [No Abstract]   [Full Text] [Related]  

  • 19. Clustering of neuronal inclusions in "dementia with neurofilament inclusions".
    Cairns NJ; Armstrong RA
    Acta Neuropathol; 2003 Aug; 106(2):125-8. PubMed ID: 12732935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies to purified cortical Lewy bodies recognize the mid-size neurofilament subunit.
    Galvin JE; Lee VM; Baba M; Mann DM; Dickson DW; Yamaguchi H; Schmidt ML; Iwatsubo T; Trojanowski JQ
    Ann Neurol; 1997 Oct; 42(4):595-603. PubMed ID: 9382471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.